Accelerating cancer research with proteomics

Supported by Olink Proteomics, part of Thermo Fisher Scientific

 Exclusive session for the Italian Liquid Biopsy Society

Proteomics is adding a new layer of insight to liquid biopsy, enabling deeper understanding of cancer biology and accelerating biomarker discovery.

This session brings together leading researchers to showcase how high-throughput proteomics supports translational research in oncology.

Agenda

3:00 pm – 3:10 pm
Introduction to Olink Technology and Applications
Speaker: Paula Perin, Marketing Manager, Olink Proteomics, Part of Thermo Fisher Scientific

---

3:10 pm – 3:25 pm
Leveraging Olink Technology for Advancing Translational Medicine
Speaker: Margherita Ferretti, IFO – Istituto Nazionale Tumori Regina Elena

---

3:25 pm – 3:40 pm
Extracellular Vesicles in COPD as Early Biomarkers and Modulators of Lung Tumorigenesis through Microenvironmental Remodeling
Speaker: Orazio Fortunato, IRCCS Istituto Nazionale dei Tumori Foundation, Milan
Orazio Fortunato – EVIta Society

3:40 pm – 3:45 pm
Closing remarks
Speaker: Davide Nocco, Business Development Manager, Olink Proteomics, Part of Thermo Fisher Scientific

3:45 pm - 4:00 pm Live Q&A

Moderator: Professor Gennaro Ciliberto